Study Group: Cardiologists who Treat Angina (US)(?)
Council Members in this Study Group: 129
Request a survey with this Study Group
Leading Experts in this Study Group
Professor of Medicine
Finch University of Health Science-Chicago Medical School
Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is a Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School, Illinois. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Dr. Arora is also Chief of Cardiology at the North...
Clinical Director
NYU Medical Center
Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...
Clinical Professor of Medicine
University of California, Los Angeles
Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has...
Owner
Joshua M. Feuer, MD
Joshua Feuer, MD, FACC, is a board certified Cardiologist in solo private practice in Santa Barbara, California. He also serves as a Consulting Cardiologist at Santa Barbara Cottage Hospital. Dr. Feuer specializes in aggressive preventive cardiology and cardiovascular risk assessment and reduction....
John Litton Jr., MDChief Executive Officer and President
Litton Family Medicine, PC
J. Scott Litton, Jr., MD, FAAFP, is the Chief Executive Officer and President of Litton Family Medicine, PC in Pennington Gap, VA. He provides inpatient services and also serves as the Medical Director of the Center for Wound Care at Lee Regional Medical Center. Dr. Litton serves as a Faculty member...
Samuel Butman, MDInterventional Cardiologist
Verde Valley Heart LLC
Samuel Butman, MD, is an Interventional Cardiologist at Verde Valley Medical Center. Dr. Butman is also a Clinical Associate Professor of Medicine at University Medical Center in Tucson, Arizona. He has also served as the Director of Cardiology Interventional Fellows Program and Director of Cardiac...
Inder Anand, MD, FACC, FRCP, DPhilDirector of the Heart Failure Program
Minneapolis VA Medical Center
Inder Anand, MD, FACC, FRCP, DPhil, is Professor of Medicine at the University of Minnesota. Dr. Anand is also Director of the Heart Failure Program at the Minneapolis VA Medical Center. Dr. Anand has expertise in pathophysiology and management of heart failure. He has been a principal investigator...
Bernard Chaitman, MDProfessor and Director
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Bernard Chaitman, MD, is Professor of Internal Medicine and Director of Cardiovascular Research at the St. Louis University School of Medicine in Missouri. He is also the Director of the Core ECG Laboratory. Dr. Chaitman has research interests in anti-anginal drug therapies, including Ranolazine, Nicorandil,...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
I am a heavy user of ARB's and Tekturna. This article does not really show anything of significance. Most practicing physicians have seen much better results and much better tolerability with ARB's than diuretics. I do not think this is going to change prescribing habits of anyone. ...
It is well known that the addition of thiazide diuretic to ACEI or ARB treatment adds about 10 mm Hg reduction on top of the 10 mm Hg reduction provided by the ACEI or ARB agent. It is expected that blocking renin in the renin angiotensin system with Tekturna would provide a similar result.
Patients with rare malignancies, especially those with already metastatic diseases, are being treated with novel oncologic agents. However, as is being seen with many drugs, the hemodynamic consequences of these agents, in many cases a rise in blood pressure, may lead to cardiovascular consequences. ...
I anticipate vytorin and zetia sales will be down substantial when the IMS numbers come out tommorrow, but that this will be only the beginning of a negative trend for these scripts. I list below several reasons why.
TRITON-TIMI 38 study of 13,608 patients with ACS compared prasugrel against clopidogrel, combined with aspirin. Prasugrel reduced the combined rate of CV death, MI or stroke (12.1% for clopidogrel vs. 9.9% for prasugrel). The benefit came at a cost of increased serious bleeding (1.4%, vs....
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Partner
- Physician - Division Head
- President
- Medical Director
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

